Mad Money Uncovered...
Health Care: Drugs
Hyperion Therapeutics Inc (HPTX: NASDAQ)
$21.64 -0.69 | -3.09%
05/20/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:1.10
Price Earnings Comparisons:
| HPTX | Sector Avg. | S&P 500 |
|---|---|---|
| 1.10 | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 17.84 | 0.00 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for HPTX:
| EBITDA | -28.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.01 | $-0.21 | $-0.73 | $0.87 |
| Number of Analysts | 2 | 2 | 2 | 2 |
| High Estimate | $0.03 | $0.10 | $-0.21 | $0.94 |
| Low Estimate | $-0.06 | $-0.52 | $-1.24 | $0.79 |
| Prior Year | $-15.26 | $0.44 | $-4.45 | $-0.73 |
| Growth Rate (Year over Year) | 99.90% | -147.73% | 83.71% | 219.31% |
Portfolios with HPTX
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
Latest HPTX Headlines from TheStreet
- Hyperion Therapeutics Added To NASDAQ Biotechnology Index (NBI) 05.16.13 | 04:05 pm
- Hyperion Therapeutics Announces First Quarter 2013 Operating Results 05.09.13 | 04:05 pm
- Hyperion Therapeutics To Report First Quarter 2013 Financial Results After Market On May 9, 2013 05.06.13 | 06:05 pm
- Hyperion Therapeutics Receives Orphan Drug Exclusivity From FDA 05.02.13 | 09:05 am
- Hyperion Therapeutics Exercises Option To Acquire Rights To BUPHENYL(R) And AMMONUL(R) 05.02.13 | 09:05 am
- Hyperion Therapeutics Becomes Oversold (HPTX) 05.01.13 | 12:05 pm
- Hyperion Therapeutics To Present At Needham's 12th Annual Healthcare Conference 04.25.13 | 04:04 pm
- Hyperion Therapeutics Issued Key Patent Pertaining To Use Of Fasting Ammonia 04.16.13 | 04:04 pm
- Hyperion Therapeutics Completes Follow-On Offering And Announces Exercise Of Underwriters' Over-Allotment Option 03.13.13 | 04:03 pm
- Hyperion Therapeutics Announces Pricing Of Follow-On Offering 03.08.13 | 09:03 am
Press Releases for HPTX
- Hyperion Therapeutics Completes Initial Public Offering And Announces Exercise Of Underwriters’ Over-Allotment Option - Business Wire 07.31.12 | 04:07 pm
- Hyperion Therapeutics Announces Pricing Of Initial Public Offering - Business Wire 07.26.12 | 08:07 am
Partner Headlines for HPTX
